212 related articles for article (PubMed ID: 38338373)
1. Cytotoxicity Enhancement in Osteosarcoma with Multifunctional I-131 Radiotherapeutic Nanoparticles: In Vitro Three-Dimensional Spheroid Model and Release Kinetics Modeling.
Marshall SK; Taweesap M; Saelim B; Pachana V; Benlateh N; Sangangam S; Bumrungsin A; Kholo-Asae H; Wongtechanon I
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338373
[TBL] [Abstract][Full Text] [Related]
2. Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model.
Marshall SK; Saelim B; Taweesap M; Pachana V; Panrak Y; Makchuchit N; Jaroenpakdee P
Nanomaterials (Basel); 2022 Oct; 12(19):. PubMed ID: 36234645
[TBL] [Abstract][Full Text] [Related]
3. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
Qiu R; Sun D; Bai Y; Li J; Wang L
Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
[TBL] [Abstract][Full Text] [Related]
4. Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.
Talaei F; Azizi E; Dinarvand R; Atyabi F
Int J Nanomedicine; 2011; 6():1963-75. PubMed ID: 21976973
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
Li Y; Hou H; Zhang P; Zhang Z
Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
[TBL] [Abstract][Full Text] [Related]
6. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
[TBL] [Abstract][Full Text] [Related]
7. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
Cao J; Zhu C; Cao Z; Ke X
Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
[TBL] [Abstract][Full Text] [Related]
8. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
9. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
10. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
11. Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
Huang WT; Larsson M; Wang YJ; Chiou SH; Lin HY; Liu DM
Mol Pharm; 2015 Apr; 12(4):1242-9. PubMed ID: 25760774
[TBL] [Abstract][Full Text] [Related]
12. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Hornicek FJ; Mankin H; Amiji MM; Duan Z
BMC Cancer; 2009 Nov; 9():399. PubMed ID: 19917123
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
15. EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles.
Tsai WH; Yu KH; Huang YC; Lee CI
Int J Nanomedicine; 2018; 13():903-916. PubMed ID: 29445279
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
17. Curcumin in human osteosarcoma: From analogs to carriers.
Lu KH; Lu PW; Lin CW; Yang SF
Drug Discov Today; 2023 Feb; 28(2):103437. PubMed ID: 36372327
[TBL] [Abstract][Full Text] [Related]
18. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
19. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model.
Rudnick-Glick S; Corem-Salkmon E; Grinberg I; Margel S
J Nanobiotechnology; 2016 Dec; 14(1):80. PubMed ID: 27919267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
